Fingerprint
Dive into the research topics of 'Evidence of trospium’s ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Evidence of trospium’s ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results
Alan Breier, Stephen K. Brannan, Steven M. Paul, Andrew C. Miller
Research output: Contribution to journal › Article › peer-review
30
Scopus
citations